Objective To observe the level of serum Meteorin-like protein(Metrnl)in patients with type 2diabetes mellitus(T2DM)complicated with non-alcoholic fatty liver disease(NAFLD).To explore the predictive value of serum Metrnl for the occur-rence of NAFLD in T2DM patients.Methods From January 2022 to June 2023,218 patients with T2DM were initially diagnosed in the Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University(Xuzhou First People's Hospital).According to whether NAFLD was combined,they were divided into T2DM group(n=105)and T2DM combined with NAFLD group(n=113).The general information,related biochemical and metabolic indicators of the two groups of patients were collected,and the serum Metrnl levels of the two groups were detected by enzyme-linked immunosorbent assay(ELISA).Results Homeostasis model assessment insulin resistance index(HO-MA-IR),glycosylated hemoglobin(HbA1c)and triglyceride(TG)in T2DM combined with NAFLD group were higher than those in T2DM group,while high-density lipoprotein cholesterol(HDL-C)and Metrnl were lower than those in T2DM group,and the differ-ences were statistically significant(P＜0.05).Logistic regression results showed that body mass index(BMI)and TG were risk factors for T2DM with NAFLD(OR＞1,P＜0.05),HDL-C and Metrnl were protective factors for T2DM with NAFLD(OR＜1,P＜0.05).Spearman correlation analysis showed that Metrnl was negatively correlated with TG,HbA1c,HOMA-IR and BMI in initially diagnosed T2DM patients(r＜0,P＜0.05),and positively correlated with HDL-C(r＞0,P＜0.05).Receiver operating characteristic(ROC)curve analysis show that,the area under the curve(AUC)of BMI,TG,HDL-C and Metrnl predicting T2DM combined with NAFLD was 0.719,0.701,0.736 and 0.771.The AUC of Metrnl was largest.Conclusion The serum Metrnl levels in initially diagnosed T2DM combined with NAFLD patients are lower than those in simple T2DM patients,and serum Metrnl levels has good predictive power for the presence of NAFLD in initially diagnosed T2DM patients.

Respiratory syncytial virus (RSV) is an enveloped, negative-sense, single-stranded RNA virus of the Orthopneumovirus  genus of the Pneumoviridae family in the order Mononegavirales. RSV can cause acute upper and lower respiratory tract infections, sometimes with extrapulmonary complications. The disease burden of RSV infection is enormous, mainly affecting infants and older adults aged 75 years or above. Currently, treatment options for RSV are largely supportive. Prevention strategies remain a critical focus, with efforts centered on vaccine development and the use of prophylactic monoclonal antibodies. To date, three RSV vaccines have been approved for active immunization among individuals aged 60 years and above. For children who are not eligible for these vaccines, passive immunization is recommended. A newly approved prophylactic monoclonal antibody, Nirsevimab, which offers enhanced neutralizing activity and an extended half-life, provides exceptional protection for high-risk infants and young children. This review provides a comprehensive and detailed exploration of RSV's virology, immunology, pathogenesis, epidemiology, clinical manifestations, treatment options, and prevention strategies.
Humans ; Respiratory Syncytial Virus Infections/prevention & control* ; Respiratory Syncytial Viruses/pathogenicity* ; Respiratory Syncytial Virus, Human/pathogenicity* ; Antiviral Agents/therapeutic use*

The global COVID-19 coronavirus pandemic has infected over 109 million people, leading to over 2 million deaths up to date and still lacking of effective drugs for patient treatment. Here, we screened about 1.8 million small molecules against the main protease (M^pro) and papain like protease (PL^pro), two major proteases in severe acute respiratory syndrome-coronavirus 2 genome, and identified 1851M^pro inhibitors and 205 PL^pro inhibitors with low nmol/l activity of the best hits. Among these inhibitors, eight small molecules showed dual inhibition effects on both M^pro and PL^pro, exhibiting potential as better candidates for COVID-19 treatment. The best inhibitors of each protease were tested in antiviral assay, with over 40% of M^pro inhibitors and over 20% of PL^pro inhibitors showing high potency in viral inhibition with low cytotoxicity. The X-ray crystal structure of SARS-CoV-2 M^pro in complex with its potent inhibitor 4a was determined at 1.8 Å resolution. Together with docking assays, our results provide a comprehensive resource for future research on anti-SARS-CoV-2 drug development.
Humans ; Antiviral Agents/chemistry* ; COVID-19 ; COVID-19 Drug Treatment ; High-Throughput Screening Assays ; Molecular Docking Simulation ; Protease Inhibitors/chemistry* ; SARS-CoV-2/enzymology* ; Viral Nonstructural Proteins

In recent studies,obesity is a risk factor for a variety of cancers,including breast cancer and colorectal cancer.Obesity can regulate the tumorigenesis and development of cancer by some factors,such as insulin and insulin-like growth factor-1 (IGF-1),leptin,fat cytokines and hormones.Understanding the relationship between obesity and cancer can provide a new perspective for the prevention and treatment of cancer.